MassARRAY variant panel
The MassARRAY SARS-CoV-2 Variant Panel (RUO) is a robust, cost-effective, and accurate testing solution, enabling laboratories to detect and differentiate 16 unique SARS-CoV-2 variants including Omicron and Delta. Moreover, labs can process up to 100s or 1000s of samples on a single instrument in a single workday. Agena Bioscience
SARS-CoV-2 variant reference material
AccuPlex SARS-CoV-2 Omicron Variant Reference Material mimics wild-type pathogenic viruses but is safe, noninfectious, and replication-deficient. With a protein coat and lipid bilayer, this reference material serves as a true, full-process, quality solution that challenges the entire PCR test procedure, making it a preferred alternative to infectious materials. LGC Clinical Diagnostics
SARS-CoV-2 variant test kit
The NEXTFLEX Variant-Seq SARS-CoV-2 Kit v2 detects all mutations associated with SARS-CoV-2 variants in a PCR-positive sample. With the incorporation of normalization beads, this kit reduces turn-around time by three hours. 1,536 UDIs incorporated in the kit enable the sequencing of 6,000 SARS-CoV-2 libraries in one flow cell. PerkinElmer
rRNA NAAT test for women’s health
Hologic’s Aptima Mycoplasma genitalium assay is a highly sensitive, rRNA-based NAAT that can detect characteristically low M. gen bacterial loads with up to 100% sensitivity. The Aptima assay is designed for a one-step, direct-load workflow on the Panther system. Hologic
Multiplex testing
The QIAstat-Dx Analyzer from Qiagen automates multiplex respiratory testing with less than one minute of hands-on time. It provides comprehensive results for more than 20 pathogens in about an hour. Ct values viewable for detected pathogens. Qiagen
Point-of-care solution
Using Bulk Acoustic Wave (BAW) detection technology, the Qorvo Omnia platform is designed to deliver rapid test results (about 20 minutes) for SARS-CoV-2 infections. BAW enables surface-based mass measurement using high frequency and surface binding, which enables a high degree of sensitivity. Qorvo
PCR testing at the point-of-care
The cobas Liat PCR System enables healthcare providers to receive rapid, confirmatory results for respiratory infections and other infectious diseases in 20 minutes or less at the point of care. The technology offers a “walkaway” workflow and a compact, portable design that is designed for any CLIA-waived healthcare setting. Roche has expanded the cobas Liat assay menu with multiplex testing and new disease states. Roche
SARS-CoV-2 test
The T2SARS-CoV-2 Panel is a qualitative T2 Magnetic Resonance (T2MR) test designed for the direct detection of nucleic acid from SARS-CoV-2 in upper respiratory specimens in transport media from individuals with signs and symptoms of COVID-19. The Panel is available for use on the T2Dx Instrument under the U.S. Food and Drug Administration Emergency Use Authorization (EUA). T2 Biosystems
